News & Updates
Filter by Specialty:
Triple, quadruple combos a useful strategy for early management of hypertension
Low-dose drug combinations that incorporate between three and four blood pressure (BP)-lowering medications appear to be well tolerated and effective for the initial or early management of hypertension, according to the results of a systematic review and meta-analysis.
Triple, quadruple combos a useful strategy for early management of hypertension
17 May 2023
Rivaroxaban for prophylactic anticoagulation in COVID-19 strikes out
The use of rivaroxaban in nonhospitalized patients with symptomatic COVID-19 falls short of reducing the composite endpoint of venous and arterial thrombotic events, hospitalization, and death, according to data from PREVENT-HD*.
Rivaroxaban for prophylactic anticoagulation in COVID-19 strikes out
16 May 2023
Fixed-dose combo tackles PD symptoms while minimizing daytime sleepiness
P2B001, an investigational drug formulation that combines extended release (ER) doses of pramipexole and rasagiline, shows promise in managing Parkinson’s Disease (PD), conferring symptom control similar to that achieved with the marketed ER pramipexole while reducing the troublesome side effect of excessive daytime sleepiness.
Fixed-dose combo tackles PD symptoms while minimizing daytime sleepiness
16 May 2023
CKD patients with intracerebral haemorrhage face poor prognosis
Poor outcomes hound several patients with chronic kidney disease (CKD) who develop intracerebral haemorrhage, reveals a study presented at the recent AAN 2023.
CKD patients with intracerebral haemorrhage face poor prognosis
16 May 2023
Algorithm useful in evaluating COVID-19 reinfection cases in Singapore
A study from Singapore demonstrated the usefulness of a systematic programme using combined microbiologic, serologic, and genomic criteria to assess possible COVID-19 reinfection cases.